Symbol Lookup

Wednesday April 23, 2014 7:27 PM ET. Data delayed 15 minutes.
0.20
0.03 (17.00%)
Bid/Lots
0.17/50
Ask/Lots
0.22/50
Open/Prev Close
0.20/0.17
Day Range
0.16-0.20
52-Week Range
0.13-0.45
Vol/Avg Daily Vol
8.4K/55.7K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
No documents available

Company Information

CardioGenics Holdings Inc., incorporated on December 16, 1997, is a development-stage company. The Company develops technology and products targeting the immunoassay segment of the in vitro diagnostic (IVD) testing market. Its CardioGenics products include QL Care Analyzer (QLCA), Cardiovascular Tests and Paramagnetic Beads. The QLCA represents a shift in the design of point-of-care (POC) analyzers. The QLCA is a small, portable, stand-alone and completely automated point-of-care immunoassay analyzer. The Company has developed four immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack. The Company has developed a process that coats the beads with a layer of silver, making them white, and more sensitive to light.

CONTACT INFORMATION

HeadquartersUnit 8, 6295 Northam Drive
MISSISSAUGA, ON, Canada L4V 1W8
Phone905-673-8501
Fax--

EXECUTIVE OFFICERS

Acting Independent Chairman of the BoardJ.Neil Tabatznik
Chief Executive Officer, DirectorYahia Gawad
Chief Financial OfficerJames Essex
Corporate Secretary, DirectorLinda Sterling
Independent DirectorAlexander Reid

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$6.2MBeta1.96
Revenue (TTM)$160.00EPS$-0.02
Shares Out.36.2MBook Value$0.00
CardioGenics Holdings Inc does not pay a dividend.P/E--
Price/Sales (TTM)38,439.0
P/Cash Flow (TTM)--
Operating Margin-629,237.50%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample